Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary A Anderson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gene|October 15, 2003
Neutral ceramidase gene: role in regulating ceramide-induced apoptosisMoonsuk S Choi, Mary A Anderson, Zhongjian Zhang, et al.
Internal Medicine Journal|March 21, 2025
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry reportArina Martynchyk, Cameron Wellard, Eliza Chung, et al.
Internal Medicine Journal|June 17, 2024
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceMasa Lasica, Mary A Anderson, Alex Boussioutas, et al.
Blood Advances|January 17, 2024
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommonThomas E Lew, Rory Bennett, Victor S Lin, et al.
Internal Medicine Journal|September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statementMary A Anderson, Rory Bennett, Xavier Badoux, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gene|October 15, 2003
Neutral ceramidase gene: role in regulating ceramide-induced apoptosisMoonsuk S Choi, Mary A Anderson, Zhongjian Zhang, et al.
Internal Medicine Journal|March 21, 2025
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry reportArina Martynchyk, Cameron Wellard, Eliza Chung, et al.
Internal Medicine Journal|June 17, 2024
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceMasa Lasica, Mary A Anderson, Alex Boussioutas, et al.
Blood Advances|January 17, 2024
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommonThomas E Lew, Rory Bennett, Victor S Lin, et al.
Internal Medicine Journal|September 24, 2023
Chronic lymphocytic leukaemia Australasian consensus practice statementMary A Anderson, Rory Bennett, Xavier Badoux, et al.
Pageof 1